BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1461622)

  • 1. Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
    Venner P
    Oncology; 1992; 49 Suppl 2():22-7. PubMed ID: 1461622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in treatment of advanced carcinoma of the prostate.
    Venner PM
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):73-7. PubMed ID: 2259929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
    Geller J
    Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate in relapsed carcinoma of prostate.
    Daniel F; MacLeod PM; Tyrrell CJ
    Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
    Pilepich MV; Buzydlowski JW; John MJ; Rubin P; McGowan DG; Marcial VA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):175-80. PubMed ID: 7721614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
    Crombie C; Raghavan D; Page J; Woods R; Dalley D; Devine R; Rosen M
    Br J Urol; 1987 May; 59(5):443-6. PubMed ID: 3594101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
    Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.
    Venner PM; Klotz PG; Klotz LH; Stewart DJ; Davis IR; Orovan WL; Ramsey EW
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):62-7. PubMed ID: 3285485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
    Dawson NA; McLeod DG
    J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07.
    Pilepich MV; Krall JM; John MJ; Rubin P; Porter AT; Marcial VA; Martz KL
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):813-7. PubMed ID: 2646266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
    Geller J; Albert J; Yen SS; Geller S; Loza D
    J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy.
    McLeod DG; Murphy GP; Priore R
    Urology; 1988 Nov; 32(5):431-6. PubMed ID: 2973171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogenic drugs.
    McLeod DG
    Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
    Smith JA
    J Urol; 1994 Jul; 152(1):132-4. PubMed ID: 8201642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate for treatment of advanced carcinoma of the prostate.
    Johnson DE; Kaesler KE; Ayala AG
    J Surg Oncol; 1975; 7(1):9-15. PubMed ID: 1177459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
    Patel SR; Kvols LK; Hahn RG; Windschitl H; Levitt R; Therneau T
    Cancer; 1990 Aug; 66(4):655-8. PubMed ID: 2201425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical castration using megestrol acetate and minidose estrogen.
    Johnson DE; Babaian RJ; Swanson DA; von Eschenbach AC; Wishnow KI; Tenney D
    Urology; 1988 May; 31(5):371-4. PubMed ID: 3284149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
    Geller J; Albert J
    Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
    Allegra JC
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.